HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SCH 479833

an angiogenesis inhibitor and antineoplastic agent; structure in first source

Also Known As:

SCH-479833; SCH479833

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bond, Richard: 1 article (04/2009)
2.	Mayer-Ezell, Rosemary: 1 article (04/2009)
3.	Nannuru, Kalyan C: 1 article (04/2009)
4.	Sadanandam, Anguraj: 1 article (04/2009)
5.	Singh, Rakesh K: 1 article (04/2009)
6.	Singh, Seema: 1 article (04/2009)
7.	Varney, Michelle L: 1 article (04/2009)

Related Diseases

1.	Neoplasms (Cancer) 04/01/2009 - "Treatment of melanoma cells with SCH-479833 or SCH-527123 also inhibited tumor growth. " 04/01/2009 - "For in vivo studies, A375SM cells were implanted subcutaneously into athymic nude mice followed by administration of SCH-479833, SCH-527123, or hydroxypropyl-beta-cyclodextrin (20%) orally for 21 days and their effect on tumor growth and angiogenesis was evaluated. "
2.	Melanoma (Melanoma, Malignant) 04/01/2009 - "Our data show that SCH-479833 or SCH-527123 inhibited the melanoma cell proliferation, chemotaxis, and invasive potential in vitro. " 04/01/2009 - "Human A375SM melanoma cells were treated with SCH-479833 or SCH-527123, and their effect on proliferation, motility, and invasion was evaluated in vitro. " 04/01/2009 - "Treatment of melanoma cells with SCH-479833 or SCH-527123 also inhibited tumor growth. "

Related Drugs and Biologics

1.	2-Hydroxypropyl-beta-cyclodextrin
2.	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamide